


To provide a portfolio designed to achieve income by investing primarily in US equities in any economic sector whilst participating in long term capital growth.
| Name | % Net Assets |
|---|---|
| Exxon Mobil | 4.2% |
| Pfizer | 3.6% |
| Chevron | 3.2% |
| Verizon Communications | 3.1% |
| Johnson & Johnson | 3.1% |
| Merck & Co | 2.9% |
| Wells Fargo | 2.4% |
| Conoco Phillips | 2.0% |
| Philip Morris International | 1.9% |
| United Technologies | 1.8% |
| Key | % Net Assets |
|---|---|
| 4.2% | |
| 3.6% | |
| 3.2% | |
| 3.1% | |
| 85.9% |
| Date | 09-Sep-2022 |
|---|---|
| NAV | 213.90p |
| Currency | GBP |
| Change | 0.30p |
| % | 0.14% |
| YTD change | 213.90p |
| YTD % | n/a |
| Fund Inception | 15/12/2008 |
|---|---|
| Fund Manager | n/a |
| TER | 1.68 (31-Jan-2013) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £100 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 4.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research